The authors would like to thank Daphne Dijkman for the language editing.
The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
See JNCCN.org for supplemental online content.
Ferlay J, Soerjomataram I, Dikshit R et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014;136:E359–386.
Izbicki JR, Hosch SB, Knoefel WT et al.. Extended resections are beneficial for patients with locally advanced colorectal cancer. Dis Colon Rectum 1995;38:1251–1256.
Saha AK, Smith KJE, Sue-Ling H et al.. Prognostic factors for survival after curative resection of Dukes' B colonic cancer. Colorectal Dis 2011;13:1390–1394.
Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol 2012;13:1152–1160.
van Leersum NJ, Snijders HS, Wouters MW et al.. Evaluating national practice of preoperative radiotherapy for rectal cancer based on clinical auditing. Eur J Surg Oncol 2013;39:1000–1006.
Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA et al.. Variation in case-mix between hospitals treating colorectal cancer patients in the Netherlands. Eur J Surg Oncol 2011;37:956–963.
Amri R, Bordeianou LG, Sylla P, Berger DL. Association of radial margin positivity with colon cancer. JAMA Surg 2015;150:890–898.
Khan MA, Hakeem AR, Scott N, Saunders RN. Significance of R1 resection margin in colon cancer resections in the modern era. Colorectal Dis 2015;17:943–953.
Elnahas A, Sunil S, Jackson TD et al.. Laparoscopic versus open surgery for T4 colon cancer: evaluation of margin status. Surg Endosc 2016;30:1491–1496.
Campos FG, Calijuri-Hamra MC, Imperiale AR et al.. Locally advanced colorectal cancer: results of surgical treatment and prognostic factors. Arq Gastroenterol 48:270–275.
Gezen C, Kement M, Altuntas YE et al.. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol 2012;10:39.
Hoffmann M, Phillips C, Oevermann E et al.. Multivisceral and standard resections in colorectal cancer. Langenbecks Arch Surg 2012;397:75–84.
Gietelink L, Henneman D, van Leersum NJ et al.. The influence of hospital volume on circumferential resection margin involvement: results of the Dutch Surgical Colorectal Audit. Ann Surg 2016;263:745–750.
Govindarajan A, Coburn NG, Kiss A et al.. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst 2006;98:1474–1481.
Cukier M, Smith AJ, Milot L et al.. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experience. Eur J Surg Oncol 2012;38:677–682.
Mohan HM, Evans MD, Larkin JO et al.. Multivisceral resection in colorectal cancer: a systematic review. Ann Surg Oncol 2013;20:2929–2936.
Gebhardt C, Meyer W, Ruckriegel S, Meier U. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg 1999;384:194–199.
Darakhshan A, Lin BPFC, Chan C et al.. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann Surg 2008;247:650–658.
Cirocchi R, Partelli S, Castellani E et al.. Right hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum. Surg Oncol 2014;23:92–98.
Zhang J, Leng J, Qian H et al.. En bloc pancreaticoduodenectomy and right colectomy in the treatment of locally advanced colon cancer. Dis Colon Rectum 2013;56:874–880.
Stojadinovic A, Nissan A, Wainberg Z et al.. Time-dependent trends in lymph node yield and impact on adjuvant therapy decisions in colon cancer surgery: an international multi-institutional study. Ann Surg Oncol 2012;19:4178–4185.
Scott N, Jamali A, Verbeke C et al.. Retroperitoneal margin involvement by adenocarcinoma of the caecum and ascending colon: what does it mean? Color Dis 2008;10:289–293.
Vignali A, Ghirardelli L, Di Palo S et al.. Laparoscopic treatment of advanced colonic cancer: a case-matched control with open surgery. Color Dis 2013;15:944–948.
Shukla PJ, Trencheva K, Merchant C et al.. Laparoscopic resection of T4 colon cancers: is it feasible? Dis Colon Rectum 2015;58:25–31.
Arredondo J, Pastor C, Baixauli J et al.. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer. Colorectal Dis 2013;15:552–557.
Karoui M, Rullier A, Luciani A et al.. Neoadjuvant FOLFOX 4 versus FOLFOX 4 with cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial - the PRODIGE 22 - ECKINOXE trial. BMC Cancer 2015;15:511.
- Search Google Scholar
- Export Citation
. Karoui M Rullier A Luciani A Neoadjuvant FOLFOX 4 versus FOLFOX 4 with cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial - the PRODIGE 22 - ECKINOXE trial. BMC Cancer 2015; 15: 511.
Hallet J, Zih FS, Lemke M et al.. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer. Eur J Surg Oncol 2014;40:706–712.
van Santvoort HC, Braam HJ, Spekreijse KR et al.. Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors. Ann Surg Oncol 2014;21:1686–1691.
Huh JW, Kim HR. The feasibility of laparoscopic resection compared to open surgery in clinically suspected T4 colorectal cancer. J Laparoendosc Adv Surg Tech A 2012;22:463–467.
Kim IY, Kim BR, Kim YW. The short-term and oncologic outcomes of laparoscopic versus open surgery for T4 colon cancer. Surg Endosc 2016;30:1508–1518.